Perspective Therapeutics Inc $CATX

Recent News (4)

• Lantheus alpha therapy, CATX director, sells $131k in stock Investing.com · 05 Sep 2026 Lantheus alpha therapy, CATX director, sells $131k in stock
• Lantheus Holdings sells $245,609 in Perspective Therapeutics stock Investing.com · 02 Sep 2026 Lantheus Holdings sells $245,609 in Perspective Therapeutics stock
• Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs GlobeNewswire · 28 Jul 2026 SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pione…
• Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026 GlobeNewswire · 17 Jul 2026 SEATTLE, July 17, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pione…